Profile of Helen M. Piwnica-Worms

-mutant tumors treated with talazoparib, pointing to new combination therapies. She emphasizes the value of mentorship and persistence in science.

Authors

Publication Details

Journal
Proceedings of the National Academy of Sciences
Published
2026-04-13
DOI
https://doi.org/10.1073/pnas.2609807123
Primary Topic
PARP inhibition in cancer therapy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Profile of Helen M. Piwnica-Worms

Sarah C. P. Williams
Proceedings of the National Academy of Sciences
PARP inhibition in cancer therapy
article

Profile of Helen M. Piwnica-Worms

Sarah C. P. Williams
article en

Abstract

-mutant tumors treated with talazoparib, pointing to new combination therapies. She emphasizes the value of mentorship and persistence in science.

Proceedings of the National Academy of SciencesVol. 123(16)
Good health and well-being
Openalex Percentile: Top 18%
PARP inhibition in cancer therapy
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.